| 摘要 |
[Objectives]To investigate the clinical efficacy of Chaihu Shugan Powder on chronic superficial gastritis with liver-stomach disharmony syndrome.[Methods]A total of 72 patients diagnosed with chronic superficial gastritis characterized by liver-stomach disharmony syndrome between September 2023 and August 2024 were randomly assigned into two groups.The control group received treatment with western medicine,and the treatment group was administered both western medicine and Chaihu Shugan Powder.The therapeutic effects,TCM syndrome scores,adverse reactions,and recurrence rate were compared between the two groups.[Results]The total effective rate was 88.89% in the treatment group and 80.56% in the control group.The differences between the two groups were statistically significant (P<0.05),indicating that the improvement observed in the treatment group was significantly greater than that in the control group (P<0.05).In comparison to pre-treatment levels,the TCM syndrome scores for both patient groups exhibited a reduction following treatment.Notably,the extent of this reduction in the treatment group was significantly greater than that observed in the control group (P<0.05).Neither group of patients experienced serious adverse reactions during treatment.Furthermore,the recurrence rate among patients in the control group was found to be higher than that in the treatment group.[Conclusions]The clinical efficacy of Chaihu Shugan Powder in the treatment of chronic superficial gastritis with liver-stomach disharmony syndrome is significant,demonstrating a notable reduction in the recurrence rate of the condition. |
